(Q38361696)

English

A novel signaling mechanism for soluble CD95 ligand. Synergy with anti-CD95 monoclonal antibodies for apoptosis and NF-kappaB nuclear translocation

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

A novel signaling mechanism for soluble CD95 ligand. Synergy with anti-CD95 monoclonal antibodies for apoptosis and NF-kappaB nuclear translocation (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

1 reference

based on heuristic

inferred from title

Sun-Sang J Sung

3

object named as

Sun-Sang J Sung

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

5

object named as

Shyr-Te Ju

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

author name string

Sheng Xiao

1

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Satoshi Jodo

2

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Ann Marshak-Rothstein

4

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

language of work or name

0 references

publication date

21 October 2002

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

277

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

52

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

50907-50913

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206093200

21 January 2018

Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206093200

21 January 2018

The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206093200

21 January 2018

Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206093200

21 January 2018

Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206093200

21 January 2018

Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206093200

21 January 2018

Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206093200

21 January 2018

Inducible nonlymphoid expression of Fas ligand is responsible for superantigen-induced peripheral deletion of T cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206093200

21 January 2018

Participation of target Fas protein in apoptosis pathway induced by CD4+ Th1 and CD8+ cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206093200

21 January 2018

Monoclonal antibody-mediated tumor regression by induction of apoptosis.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206093200

21 January 2018

A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206093200

21 January 2018

Lethal effect of the anti-Fas antibody in mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206093200

21 January 2018

Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206093200

21 January 2018

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206093200

21 January 2018

The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206093200

21 January 2018

The CD95 (APO-1/Fas) receptor activates NF-kappaB independently of its cytotoxic function

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206093200

21 January 2018

Regulation of apoptosis and T cell activation by Fas-specific mAb.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206093200

21 January 2018

Gene transfer of Fas ligand induces tumor regression in vivo

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206093200

21 January 2018

Metalloproteinase-mediated release of human Fas ligand

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206093200

21 January 2018

Regulation of the proinflammatory effects of Fas ligand (CD95L).

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206093200

21 January 2018

Opposing effects of transmembrane and soluble Fas ligand expression on inflammation and tumor cell survival

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206093200

21 January 2018

Apoptosis-inducing membrane vesicles. A novel agent with unique properties

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206093200

21 January 2018

Ceramide enables fas to cap and kill.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206093200

21 January 2018

Downregulation of Fas ligand by shedding

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206093200

21 January 2018

Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206093200

21 January 2018

The Fas protein is expressed at high levels on CD4+CD8+ thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain, MRL lpr/lpr

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206093200

21 January 2018

CD95 (Fas) ligand-expressing vesicles display antibody-mediated, FcR-dependent enhancement of cytotoxicity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206093200

21 January 2018

Bioactivities of Fas ligand-expressing retroviral particles

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206093200

21 January 2018

Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206093200

21 January 2018

Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206093200

21 January 2018

Sp1 is the major fasl gene activator in abnormal CD4(-)CD8(-)B220(+) T cells of lpr and gld mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206093200

21 January 2018

Proteasome regulation of activation-induced T cell death

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206093200

21 January 2018

Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206093200

21 January 2018

Extracellular matrix interacts with soluble CD95L: retention and enhancement of cytotoxicity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206093200

21 January 2018

Type II tumour necrosis factor-alpha receptor (TNFR2) activates c-Jun N-terminal kinase (JNK) but not mitogen-activated protein kinase (MAPK) or p38 MAPK pathways.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206093200

21 January 2018

A role for CD95 ligand in preventing graft rejection

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206093200

21 January 2018

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206093200

21 January 2018

Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206093200

21 January 2018

Fas ligand engagement of resident peritoneal macrophages in vivo induces apoptosis and the production of neutrophil chemotactic factors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206093200

21 January 2018

FasL promoter activation by IL-2 through SP1 and NFAT but not Egr-2 and Egr-3

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206093200

21 January 2018

In vivo analysis of Fas antigen-mediated apoptosis: effects of agonistic anti-mouse Fas mAb on thymus, spleen and liver

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206093200

21 January 2018

Identifiers

10.1074/JBC.M206093200

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38361696&oldid=1755795869"